Trials | Juno Research LLC

Current Trials

At Juno Research, we’re committed to advancing medicine through carefully conducted clinical trials that prioritize patient safety, transparency, and impact. Below, you'll find our current active studies. Call us to see if you qualify!

Copy of Since 2004, we have been working with top pharmaceutical companies to advance heal

Zupreme 2

This research trial is exploring the effects of a study drug in individuals with type 2 diabetes and excess weight.

Copy of Copy of Since 2004, we have been working with top pharmaceutical companies to adva

AstraZeneca BaxDuo

If you have chronic kidney disease and high blood pressure, you may qualify for a clinical trial testing a new treatment from AstraZeneca.

Copy of Copy of Copy of Since 2004, we h

Roche CT 388

A 1-weekly subcutaneous injectable, that is being developed for the treatment of obesity & Type 2 Diabetes.

Copy of Copy of Copy of Copy of Since 2004, we have been working with top pharmaceutical c

Avanti M21

If you are being treated for primary hypothyroidism but are still experiencing symptoms, you might consider enrolling.

Retatrutide

This research trial is exploring a potential treatment for (Obesity, T2D, NAFLD), and other related conditions

TRANSCEND-T2D-3

A clinical research study for people with type 2 diabetes and chronic kidney disease being treated with basal insulin alone.

Copy of Copy of Copy of Copy of Copy of Since 2004, we have been working with top pharmace

Lepodisiran

Trial to evaluate the efficacy of lepodisiran in participants who have cardiovascular disease or are at risk of a heart attack or stroke.

Copy of Copy of Copy of Copy of Copy of Copy of Copy of Copy of Since 2004, we have been w

Mounjaro

A once-weekly injection for adults with type 2 diabetes that helps lower blood sugar and may support weight loss as well.

Current Trials

Subscribe Form